The complex G protein‐coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets

GRK2 is a ubiquitous member of the G protein‐coupled receptor kinase (GRK) family that appears to play a central, integrative role in signal transduction cascades. GRKs participate together with arrestins in the regulation of G protein‐coupled receptors (GPCR), a family of hundreds of membrane proteins of key physiological and pharmacological importance, by triggering receptor desensitization from G proteins and GPCR internalization, and also by helping assemble macromolecular signalosomes in the receptor environment acting as agonist‐regulated adaptor scaffolds, thus contributing to signal propagation. In addition, emerging evidence indicates that GRK2 can phosphorylate a growing number of non‐GPCR substrates and associate with a variety of proteins related to signal transduction, thus suggesting that this kinase could also have diverse ‘effector’ functions. We discuss herein the increasing complexity of such GRK2 ‘interactome’, with emphasis on the recently reported roles of this kinase in cell migration and cell cycle progression and on the functional impact of the altered GRK2 levels observed in several relevant cardiovascular, inflammatory or tumour pathologies. Deciphering how the different networks of potential GRK2 functional interactions are orchestrated in a stimulus, cell type or context‐specific way is critical to unveil the contribution of GRK2 to basic cellular processes, to understand how alterations in GRK2 levels or functionality may participate in the onset or development of several cardiovascular, tumour or inflammatory diseases, and to assess the feasibility of new therapeutic strategies based on the modulation of the activity, levels or specific interactions of GRK2.

[1]  B. Posner,et al.  The G protein‐coupled receptor kinase‐2 is a TGFβ‐inducible antagonist of TGFβ signal transduction , 2005 .

[2]  S. Houser,et al.  G Protein-Coupled Receptor Kinase 2 Ablation in Cardiac Myocytes Before or After Myocardial Infarction Prevents Heart Failure , 2008, Circulation research.

[3]  M. Oppermann,et al.  Overexpression of G protein-coupled receptor kinase-2 in smooth muscle cells attenuates mitogenic signaling via G protein-coupled and platelet-derived growth factor receptors. , 2000, Circulation.

[4]  M. Lohse,et al.  An RNA molecule that specifically inhibits G-protein-coupled receptor kinase 2 in vitro. , 2008, RNA.

[5]  P. Crespo,et al.  Phosphorylation of p38 by GRK2 at the Docking Groove Unveils a Novel Mechanism for Inactivating p38MAPK , 2006, Current Biology.

[6]  Richard Z. Lin,et al.  Phospholipase C-independent Activation of Glycogen Synthase Kinase-3β and C-terminal Src Kinase by Gαq* , 2003, Journal of Biological Chemistry.

[7]  P. Lichter,et al.  Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays , 2006, British Journal of Cancer.

[8]  G. Borisy,et al.  Cell Migration: Integrating Signals from Front to Back , 2003, Science.

[9]  S. Milano,et al.  Regulation of receptor trafficking by GRKs and arrestins. , 2007, Annual review of physiology.

[10]  B. Berk,et al.  The multifunctional GIT family of proteins , 2006, Journal of Cell Science.

[11]  R. Perdrisot,et al.  Pathophysiological roles of G-protein-coupled receptor kinases. , 2005, Cellular signalling.

[12]  Matthew W. Foster,et al.  Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2 , 2007, Cell.

[13]  T. Fields,et al.  Inhibition of WNT signaling by G protein-coupled receptor (GPCR) kinase 2 (GRK2). , 2009, Molecular endocrinology.

[14]  M. Caron,et al.  Smoothened Signal Transduction Is Promoted by G Protein-Coupled Receptor Kinase 2 , 2006, Molecular and Cellular Biology.

[15]  David M. Harris,et al.  G Protein-Coupled Receptor Kinase 2 Expression and Activity Are Associated With Blood Pressure in Black Americans , 2009, Hypertension.

[16]  M. Lohse,et al.  Peptide inhibitors of G protein-coupled receptor kinases. , 2005, Biochemical pharmacology.

[17]  C. Murga,et al.  The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. , 2007, Biochimica et biophysica acta.

[18]  Julie A. Pitcher,et al.  Feedback Inhibition of G Protein-coupled Receptor Kinase 2 (GRK2) Activity by Extracellular Signal-regulated Kinases* , 1999, The Journal of Biological Chemistry.

[19]  E. Ziv,et al.  Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes , 2004, Diabetologia.

[20]  P. Penela,et al.  Mdm2 is involved in the ubiquitination and degradation of G‐protein‐coupled receptor kinase 2 , 2006, The EMBO journal.

[21]  W. Koch,et al.  Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure , 2007, Nature Medicine.

[22]  J A Peters,et al.  Guide to Receptors and Channels (GRAC), 3rd edition , 2008, British journal of pharmacology.

[23]  D. Leosco,et al.  The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance. , 2009, Cardiovascular research.

[24]  L. Barak,et al.  Phosphorylation of the Platelet-derived Growth Factor Receptor-β by G Protein-coupled Receptor Kinase-2 Reduces Receptor Signaling and Interaction with the Na+/H+ Exchanger Regulatory Factor* , 2004, Journal of Biological Chemistry.

[25]  Don C Rockey,et al.  A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension , 2005, Nature Medicine.

[26]  S. Haunsø,et al.  Differential G protein receptor kinase 2 expression in compensated hypertrophy and heart failure after myocardial infarction in the rat , 2003, Basic Research in Cardiology.

[27]  D. Leosco,et al.  Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. , 2005, European heart journal.

[28]  M. Caron,et al.  G Protein-Coupled Receptor Kinase 2 in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis , 2005, The Journal of Immunology.

[29]  R. Lefkowitz,et al.  β-Arrestins and Cell Signaling , 2007 .

[30]  F. Mayor,et al.  Agonist-dependent modulation of G protein-coupled receptor kinase 2 by mitogen-activated protein kinases. , 2000, Molecular pharmacology.

[31]  Eric Reiter,et al.  GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling , 2006, Trends in Endocrinology & Metabolism.

[32]  J. Ross,et al.  Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Lefkowitz,et al.  Beta-arrestins and cell signaling. , 2007, Annual review of physiology.

[34]  J. Benovic,et al.  G-Protein-coupled receptor kinase activity in hypertension : increased vascular and lymphocyte G-protein receptor kinase-2 protein expression. , 2000, Hypertension.

[35]  X. Zhang,et al.  Reduced G-protein-coupled-receptor kinase 2 activity results in impairment of osteoblast function. , 2000, Bone.

[36]  W. Koch,et al.  Myocardial Adeno-Associated Virus Serotype 6–&bgr;ARKct Gene Therapy Improves Cardiac Function and Normalizes the Neurohormonal Axis in Chronic Heart Failure , 2009, Circulation.

[37]  Antonio S. Tutor,et al.  Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease. , 2006, Cardiovascular research.

[38]  Lan Ma,et al.  EGF transregulates opioid receptors through EGFR-mediated GRK2 phosphorylation and activation. , 2008, Molecular biology of the cell.

[39]  N. Pyne,et al.  The Inhibitory γ Subunit of the Type 6 Retinal cGMP Phosphodiesterase Functions to Link c-Src and G-protein-coupled Receptor Kinase 2 in a Signaling Unit That Regulates p42/p44 Mitogen-activated Protein Kinase by Epidermal Growth Factor* , 2003, The Journal of Biological Chemistry.

[40]  J. Olefsky,et al.  Regulation of Receptor Tyrosine Kinase Signaling by GRKs and β-Arrestins , 2007 .

[41]  Kathryn A DeFea,et al.  Stop that cell! Beta-arrestin-dependent chemotaxis: a tale of localized actin assembly and receptor desensitization. , 2007, Annual review of physiology.

[42]  Lan Ma,et al.  Kinase activity-independent regulation of cyclin pathway by GRK2 is essential for zebrafish early development , 2009, Proceedings of the National Academy of Sciences.

[43]  O. Barreiro,et al.  G protein‐coupled receptor kinase 2 positively regulates epithelial cell migration , 2008, The EMBO journal.

[44]  J. Violin,et al.  Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. , 2007, The Journal of clinical investigation.

[45]  C. Murga,et al.  G protein-coupled receptor kinase 2 negatively regulates chemokine signaling at a level downstream from G protein subunits. , 2005, Molecular biology of the cell.

[46]  J. Violin,et al.  β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection , 2007 .

[47]  R. Lefkowitz,et al.  beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Guilhot,et al.  Expression and activity of g protein-coupled receptor kinases in differentiated thyroid carcinoma. , 2002, The Journal of clinical endocrinology and metabolism.

[49]  David I Cook,et al.  The kinase Grk2 regulates Nedd4/Nedd4-2-dependent control of epithelial Na+ channels. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. Benovic,et al.  G-protein-coupled-receptor kinases mediate TNFα-induced NFκB signalling via direct interaction with and phosphorylation of IκBα. , 2009, The Biochemical journal.

[51]  R. Lefkowitz,et al.  Myocardial overexpression of adrenergic receptors and receptor kinases. , 1998, Advances in pharmacology.

[52]  P. Chidiac,et al.  Dual regulation of lysophosphatidic acid (LPA1) receptor signalling by Ral and GRK. , 2009, Cellular signalling.

[53]  C. Ribas,et al.  Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. , 2003, Cellular signalling.

[54]  G. Dorn.  GRK mythology: G-protein receptor kinases in cardiovascular disease , 2009, Journal of Molecular Medicine.

[55]  R. Lefkowitz,et al.  Activity-Dependent Internalization of Smoothened Mediated by ß-Arrestin 2 and GRK2 , 2004, Science.

[56]  M. Caron,et al.  Phosphoinositide 3-kinase regulates β2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/β-arrestin complex , 2002, The Journal of cell biology.

[57]  David M. Harris,et al.  Inhibition of vascular smooth muscle G protein-coupled receptor kinase 2 enhances alpha1D-adrenergic receptor constriction. , 2008, American journal of physiology. Heart and circulatory physiology.

[58]  R. Lefkowitz,et al.  Purification, crystallization and preliminary X-ray diffraction studies of a complex between G protein-coupled receptor kinase 2 and Gbeta1gamma2. , 2003, Acta crystallographica. Section D, Biological crystallography.

[59]  P. Penela,et al.  MAPK-dependent Degradation of G Protein-coupled Receptor Kinase 2* , 2003, Journal of Biological Chemistry.

[60]  C. Rojek.  Mechanisms of Regulation , 1999 .

[61]  Verónica Rivas,et al.  G protein–coupled receptor kinase 2 (GRK2) modulation and cell cycle progression , 2009, Proceedings of the National Academy of Sciences.

[62]  Hui-Jye Chen,et al.  TGFβ-induced GRK2 expression attenuates AngII-regulated vascular smooth muscle cell proliferation and migration , 2009 .

[63]  Eric Reiter,et al.  GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. , 2006, Trends in endocrinology and metabolism: TEM.

[64]  G. Dorn,et al.  Cardiac-Specific Ablation of G-Protein Receptor Kinase 2 Redefines Its Roles in Heart Development and &bgr;-Adrenergic Signaling , 2006, Circulation research.

[65]  R. Lefkowitz,et al.  Purification, crystallization and preliminary X-ray diffraction studies of a complex between G protein-coupled receptor kinase 2 and Gβ1γ2 , 2003 .

[66]  M. Caron,et al.  Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4 , 2004, Journal of leukocyte biology.

[67]  C. Ribas,et al.  New roles of G protein-coupled receptor kinase 2 (GRK2) in cell migration , 2009, Cell adhesion & migration.

[68]  A. Kavelaars,et al.  GRKs and arrestins: regulators of migration and inflammation , 2006, Journal of leukocyte biology.

[69]  P. Penela,et al.  Degradation of the G Protein-coupled Receptor Kinase 2 by the Proteasome Pathway* , 1998, The Journal of Biological Chemistry.

[70]  R. Penn,et al.  Analysis of the human G protein-coupled receptor kinase 2 (GRK2) gene promoter: regulation by signal transduction systems in aortic smooth muscle cells. , 2000, Circulation.

[71]  R. Gainetdinov,et al.  Physiological roles of G protein-coupled receptor kinases and arrestins. , 2007, Annual review of physiology.

[72]  F. Mayor,et al.  Agonist-dependent Phosphorylation of the G Protein-coupled Receptor Kinase 2 (GRK2) by Src Tyrosine Kinase* , 1999, The Journal of Biological Chemistry.

[73]  J. Olefsky,et al.  Regulation of receptor tyrosine kinase signaling by GRKs and beta-arrestins. , 2007, Annual review of physiology.

[74]  M. Caron,et al.  Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[75]  G. Dorn.  Novel pharmacotherapies to abrogate postinfarction ventricular remodeling , 2009, Nature Reviews Cardiology.

[76]  J. Gutkind,et al.  G-protein-coupled receptors and cancer , 2007, Nature Reviews Cancer.

[77]  P. Penela,et al.  β‐arrestin‐ and c‐Src‐dependent degradation of G‐protein‐coupled receptor kinase 2 , 2001, The EMBO journal.

[78]  S. Ferguson.  Phosphorylation-independent attenuation of GPCR signalling. , 2007, Trends in pharmacological sciences.

[79]  B. Posner,et al.  The G protein-coupled receptor kinase-2 is a TGFbeta-inducible antagonist of TGFbeta signal transduction. , 2005, The EMBO journal.

[80]  C. Molnar,et al.  The G protein-coupled receptor regulatory kinase GPRK2 participates in Hedgehog signaling in Drosophila , 2007, Proceedings of the National Academy of Sciences.

[81]  W. Koch,et al.  Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure. , 2002, Molecular pharmacology.

[82]  S. Milstien,et al.  Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics. , 2006, Cancer cell.

[83]  J A Peters,et al.  Guide to Receptors and Channels (GRAC), 2nd edition (2007 Revision). , 2007, British journal of pharmacology.

[84]  J. Benovic,et al.  G-protein-coupled receptor kinase activity is increased in hypertension. , 1997, The Journal of clinical investigation.

[85]  T. Kozasa,et al.  Snapshot of Activated G Proteins at the Membrane: The Gαq-GRK2-Gßγ Complex , 2005, Science.

[86]  E. Sahai,et al.  Integrin β1 is required for the invasive behaviour but not proliferation of squamous cell carcinoma cells in vivo , 2004, British Journal of Cancer.

[87]  Gaofeng Fan,et al.  Phospholipase C-independent activation of glycogen synthase kinase-3beta and C-terminal Src kinase by Galphaq. , 2003, The Journal of biological chemistry.

[88]  R. Lefkowitz,et al.  Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN). , 2008, Clinical immunology.

[89]  K. Kameyama,et al.  [Regulation of G protein-coupled receptor kinase activity]. , 1994, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[90]  R. Perdrisot,et al.  Immunohistochemical detection, regulation and antiproliferative function of G-protein-coupled receptor kinase 2 in thyroid carcinomas. , 2008, The Journal of endocrinology.